VitMode

Prolactin (Blood Test)

Prolactin is a pituitary hormone best known for its role in lactation, but an elevated level can also be the first sign of a pituitary tumor, hypothyroidism, medication side effects, or simply the stress of the blood draw itself.

PZdr Piotr ZielińskiReviewed by Julia WiśniewskaUpdated: September 24, 2026
Strong evidence
4.6

Number of studies

2

Safety

Requires caution

Time to effects

Not applicable — prolactin is a diagnostic test, not an intervention.

Who it's for

Women with irregular menstrual cycles, absent periods, or galactorrhea unrelated to pregnancy and breastfeedingMen with reduced libido, erectile dysfunction, gynecomastia, or unexplained infertilityPeople with infertility in either sex, as part of a broader hormonal workupPatients with a sellar mass on imaging or those taking medications that strongly block dopamine receptors
Table of contents

TL;DR

Prolactin is a pituitary hormone best known for its role in lactation, but an elevated level can also be the first sign of a pituitary tumor, hypothyroidism, medication side effects, or simply the stress of the blood draw itself.

  • Helps identify the hormonal cause of menstrual disorders, infertility, and galactorrhea in women
  • Enables detection of prolactinoma — the most common hormonally active pituitary tumor — often before neurological symptoms appear
  • Helps diagnose the cause of reduced libido, erectile dysfunction, and gynecomastia in men
Test typeProlactin concentration in blood serum
Level of evidenceStrong — a well-established test in endocrine diagnostics, with clearly described interpretation guidelines
Target groupPeople with menstrual disorders, galactorrhea, infertility, reduced libido, or suspected pituitary tumor
Key parametersProlactin concentration (ng/mL or mIU/L), supplemented if needed by PEG macroprolactin screening
PreparationMorning draw, after brief rest, avoiding stress, breast stimulation, and intense exertion before the test
StatusFirst-line diagnostic test for suspected disturbances of the pituitary-gonadal axis or a pituitary tumor

Understand

Overview

Prolactin is a peptide hormone secreted mainly by lactotroph cells of the anterior pituitary gland. It's best known for its role in initiating and sustaining lactation after childbirth, but physiologically it also plays roles in immune regulation, metabolism, and reproductive behavior in both sexes. The test measures prolactin concentration in blood serum and is one of the core tests in the endocrine workup of menstrual disorders, infertility, galactorrhea, and suspected pituitary tumors.

The clinical significance of this test stems from the fact that prolactin is under tonic inhibition by dopamine — unlike most pituitary hormones, which require stimulation to be secreted. This means that anything that disrupts dopaminergic inhibition — from a pituitary tumor compressing the pituitary stalk, to medications blocking dopamine receptors, to hypothyroidism increasing TRH secretion — can lead to hyperprolactinemia. This multiplicity of possible causes means a single elevated result rarely points to one specific diagnosis on its own and requires systematic differentiation.

The test is most often ordered for women with menstrual disorders (irregular cycles, absent periods) or galactorrhea unrelated to pregnancy and breastfeeding, for men with reduced libido, erectile dysfunction, gynecomastia, or infertility, and for unexplained infertility in either sex, as well as in the workup of masses in the sellar region seen on imaging. In patients taking antipsychotic medications, prolactin is often monitored routinely, since many of these drugs strongly block D2 dopamine receptors.

Interpreting the result requires accounting for the degree of elevation and clinical context. Moderately elevated values (usually up to around 100 ng/mL, though thresholds vary between labs) most often stem from functional causes — stress from the blood draw itself, recent breast stimulation, sleep, physical exertion, pregnancy, hypothyroidism, or medication effects. Very high values, especially above 200 ng/mL, strongly suggest a prolactinoma — a prolactin-secreting pituitary adenoma — though a definitive diagnosis always requires correlation with pituitary MRI. It's worth noting that the degree of prolactin elevation usually correlates with the tumor's size — microadenomas typically cause smaller elevations than macroadenomas.

An important source of misinterpretation is macroprolactinemia — the presence in blood of large prolactin complexes (so-called big-big prolactin), which are detected by standard immunoassays but have negligible biological activity and don't cause clinical symptoms. It's estimated that up to fifteen to twenty-five percent of apparent hyperprolactinemia cases may result from macroprolactin, which, without appropriate screening (by polyethylene glycol precipitation, PEG), leads to unnecessary imaging and treatment in asymptomatic people.

Logistically, the most important consideration is minimizing peri-draw stress, since the act of needle insertion itself can temporarily raise prolactin concentration. It's recommended to draw the sample in the morning, ideally after resting for ten to twenty minutes, fasting or after a light meal, avoiding breast stimulation and intense physical exertion right before the test. With an unexpectedly elevated result and no clinical symptoms, standard practice is to repeat the test, since a single mildly elevated result often normalizes on a repeat, calmer draw.

In summary, prolactin is a test of high diagnostic value, but its interpretation should never happen in isolation from the clinical picture, medications taken, thyroid function, and — when in doubt — macroprolactin status. It's a good example of a test where the number on the result sheet alone means relatively little without the context in which it was measured.

Mechanism of action

Prolactin is synthesized and secreted by lactotroph cells of the anterior pituitary gland, which usually make up about fifteen to twenty percent of all glandular pituitary cells, and their number and activity clearly increase during pregnancy under the influence of estrogens. Unlike most pituitary tropic hormones, prolactin secretion is active by default and kept under constant inhibitory control by dopamine, released from hypothalamic neurons into the pituitary portal vessels and acting on D2 receptors of lactotroph cells. This means that severing or compressing the pituitary stalk — for example, by a growing tumor in that region — paradoxically raises rather than lowers prolactin concentration, since it interrupts the dopamine supply that inhibits its secretion.

Besides dopamine, prolactin secretion is influenced by thyrotropin-releasing hormone (TRH), which stimulates lactotroph cells — this is exactly the mechanism that explains why primary hypothyroidism, in which TRH secretion is compensatorily increased, often accompanies mild-to-moderate hyperprolactinemia that resolves once thyroid function is corrected. Estrogens also stimulate lactotroph cells, which explains the physiological rise in prolactin during pregnancy and its fluctuations across the menstrual cycle.

The most common pathological cause of significant hyperprolactinemia is a prolactin-secreting pituitary adenoma (prolactinoma) — a benign tumor of lactotroph cells that produces excess hormone autonomously, independent of dopaminergic inhibition. Another important group of causes is medications that block D2 dopamine receptors, primarily first-generation and some second-generation antipsychotics, as well as certain antiemetics (e.g., metoclopramide), which abolish dopamine's inhibitory action regardless of the pituitary's own state.

Macroprolactinemia arises from the formation of prolactin complexes with IgG-class immunoglobulins (so-called big-big prolactin), which, due to their large molecular size, poorly penetrate vessel walls to reach target tissues and have negligible biological activity, even though they're recognized by standard immunoassays almost as readily as monomeric, active prolactin. A screening method based on polyethylene glycol (PEG) precipitation of the sample removes these large complexes before measurement, revealing the true concentration of biologically active monomeric prolactin.

1

Secretion by pituitary lactotroph cells

Prolactin is produced by lactotroph cells of the anterior pituitary, whose numbers increase under estrogen influence, especially during pregnancy.

2

Tonic dopaminergic inhibition

Unlike other pituitary hormones, prolactin secretion is active by default and constantly inhibited by hypothalamic dopamine.

3

Causes of disrupted inhibition and hypersecretion

Pituitary stalk compression, D2-receptor-blocking medications, and increased TRH secretion in hypothyroidism all lead to hyperprolactinemia through different routes.

4

Macroprolactin interference in measurement

Complexes of prolactin with IgG immunoglobulins are detected by standard assays despite negligible biological activity, requiring PEG screening.

Evidence: strong — based on 2 studies in this database.

Benefits

Helps identify the hormonal cause of menstrual disorders, infertility, and galactorrhea in women
Enables detection of prolactinoma — the most common hormonally active pituitary tumor — often before neurological symptoms appear
Helps diagnose the cause of reduced libido, erectile dysfunction, and gynecomastia in men
Facilitates distinguishing drug-induced hyperprolactinemia from structural pituitary disease, which directly affects further management
Enables detection of macroprolactinemia, helping avoid unnecessary imaging and treatment in asymptomatic people

Common myths

MythElevated prolactin always means a pituitary tumor.

FactModerately elevated values most often result from functional causes — stress, sleep, medications, or hypothyroidism. Very high values more strongly suggest a prolactinoma, but the diagnosis always requires confirmation by imaging, not the blood result alone.

MythMacroprolactinemia doesn't matter and can be ignored.

FactOn the contrary — failing to account for macroprolactin is a common cause of unnecessary imaging, unnecessary treatment, and patient anxiety, which is why an elevated but asymptomatic result is worth screening with the PEG method.

MythProlactin testing is only relevant for women and lactation.

FactProlactin is an important test for men too — its elevation can explain reduced libido, erectile dysfunction, gynecomastia, and infertility, and a workup of male hypogonadism without assessing prolactin is incomplete.

MythA single elevated result immediately confirms the diagnosis.

FactBecause prolactin is highly sensitive to stress and physiological factors, an unexpectedly elevated result without symptoms usually warrants repeating the test under calmer conditions before drawing further diagnostic conclusions.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Practice

Frequently asked questions

Reference ranges vary between labs and by sex, but generally values up to about 20–25 ng/mL in non-pregnant women and up to about 15–20 ng/mL in men are usually considered normal. Interpretation should always be made against the specific lab's reference range.

Strict fasting isn't absolutely required, but a morning draw after brief rest is recommended, avoiding prior breast stimulation, sexual activity, and intense physical exertion, since these factors can temporarily raise the result.

Macroprolactin refers to large, biologically low-activity prolactin complexes with antibodies, detected by standard tests almost as readily as active prolactin. Their presence can cause a seemingly elevated result in a person with no symptoms at all, which is why an unclear clinical picture warrants additional PEG precipitation screening.

Yes, many antipsychotic medications strongly block D2 dopamine receptors and can significantly raise prolactin — this is one of the most common reasons for monitoring this parameter in patients on such treatment.

It's worth discussing with a doctor, especially with accompanying symptoms like reduced libido, erectile dysfunction, or gynecomastia — in men, hyperprolactinemia more often than in women is the first sign of a larger, hormonally active pituitary adenoma, since symptoms tend to appear later than menstrual disturbances do in women.

What to combine with

Good combinations

TSH and Thyroid Hormones (fT3, fT4, anti-TPO)Hypothyroidism is a common, reversible cause of hyperprolactinemia, so both tests are worth assessing together

LH and FSH (Sex Hormones, Gonadotropins)Elevated prolactin suppresses GnRH secretion, lowering LH and FSH — assessing them together helps explain the cause of menstrual disorders or infertility

TestosteroneHyperprolactinemia in men is often associated with secondarily lowered testosterone through suppression of the hypothalamic-pituitary-gonadal axis

Safety

Side effects & contraindications

Possible side effects

Contraindications

No significant contraindications at typical doses.

Interactions

The stress of the blood draw and needle insertion itself can temporarily raise the result, which is why a brief rest before drawing is recommended

Prolactin concentration physiologically rises during sleep, which is why the test is usually performed in the morning, a few hours after waking

Recent breast stimulation, breast examination, sexual activity, or intense physical exertion can temporarily raise the result

Many medications affect the result — antipsychotics, metoclopramide, certain antidepressants, and antihypertensives (verapamil) raise prolactin, while dopamine agonists lower it

Pregnancy and breastfeeding physiologically raise prolactin significantly and rule out standard interpretation of the result

Kidney failure and primary hypothyroidism can raise the result independent of the pituitary's own state

Is it worth taking?

Who it's for

  • Women with irregular menstrual cycles, absent periods, or galactorrhea unrelated to pregnancy and breastfeeding
  • Men with reduced libido, erectile dysfunction, gynecomastia, or unexplained infertility
  • People with infertility in either sex, as part of a broader hormonal workup
  • Patients with a sellar mass on imaging or those taking medications that strongly block dopamine receptors

Not for

  • No significant contraindications at typical doses.

Evidence

Worth knowing

Prolactin is the only major pituitary hormone that's under default inhibition rather than stimulation — that's why damage to the pituitary stalk raises, rather than lowers, its concentration.

The size of a pituitary adenoma usually correlates with the degree of prolactin elevation — very high values more strongly suggest a macroadenoma.

As many as fifteen to twenty-five percent of apparent hyperprolactinemia cases may stem from biologically inactive macroprolactin.

The act of drawing blood itself can temporarily raise the result, which is why a brief rest before the draw is recommended, rather than testing immediately upon arrival at the lab.

Studies

Macroprolactin is a common cause of false-positive interference in prolactin assays, accounting for falsely elevated results in as many as fifteen to twenty-five percent of hyperprolactinemia cases.

Smith TP et al., Clinical Chemistry and Laboratory Medicine, 2022

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

Strong evidence

Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH · Journal of Clinical Endocrinology & Metabolism · 2011

The Endocrine Society's clinical practice guideline on diagnosing and treating hyperprolactinemia, including an algorithm for differentiating physiological, drug-related, and structural causes.

View study

Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia

Moderate evidence

Smith TP, Kelly S, Fahie-Wilson MN · Clinical Chemistry and Laboratory Medicine · 2022

An analysis of cross-reactivity of various prolactin assays with macroprolactin, and recommendations for an optimal macroprolactinemia screening policy.

View study

Sources & bibliography

Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.

Compare with similar entries

About the authors of this entry

PZ

Author

dr Piotr Zieliński

Endocrinologist

Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.

204 publications on this site

JW

Medical review

Julia Wiśniewska

Editor, Neurohacking & Sleep

Julia studied cognitive neuroscience planning an academic career, but partway through her PhD she realized she cared more about explaining research than running it. She started a podcast on sleep optimization — first for a handful of friends, now followed regularly by tens of thousands of listeners — and that podcast opened the door to writing for VitMode. She specializes in chronobiology, nootropics and recovery protocols, and her pieces often start from a question she asked herself during her own sleep experiments — including one memorable month living on a 28-hour "day," which she doesn't recommend anyone repeat. Off the clock, she sleeps surprisingly little for someone who writes about it professionally, and she's the first to laugh about it.

70 publications on this site

Published: September 24, 2026Updated: September 24, 2026

Related entries

Lekarz badający gardło i szyję pacjenta w rękawiczkach4.7

TSH and Thyroid Hormones (fT3, fT4, anti-TPO)

TSH is the first-line test for evaluating thyroid function, but on its own it rarely gives the full picture — only together with fT4, fT3, and anti-TPO can it distinguish a temporary fluctuation from an actual disorder.

Badania krwiStrong evidence
Test ciążowy obok tulipanów na różowym kalendarzu4.6

LH and FSH (Sex Hormones, Gonadotropins)

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are pituitary gonadotropins that govern the ovaries and testes — interpreting them together helps determine whether a fertility or cycle problem lies in the gonads themselves or higher up, in the brain.

Badania krwiStrong evidence
Umięśniony sportowiec w stroju treningowym4.7

Testosterone

The primary anabolic hormone — its natural level depends heavily on sleep, resistance training, body composition and fat mass.

HormonyStrong evidence
Naukowiec badający próbki pod nowoczesnym mikroskopem4.5

Estradiol During TRT — What's the Normal Range, and Do You Need to Lower It?

The concrete reference ranges for estradiol in men on TRT, why the standard immunoassay tends to be unreliable in exactly this low concentration range, and how to sensibly interpret a single result — instead of treating it as a verdict demanding immediate action.

TRTModerate evidence
Lekarz ze stetoskopem badający uśmiechniętego pacjenta w gabinecie4.4

Male Fertility and Semen Quality

A widely cited 2017 meta-analysis showed a decades-long decline in sperm counts in Western countries — we look at what's actually known about the factors affecting male fertility.

Zdrowie mężczyznModerate evidence
Model szkieletu z narządami wewnętrznymi w gabinecie medycznym4.7

Liver Panel (ALT, AST, GGT, Bilirubin)

Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.

Badania krwiStrong evidence
Dłonie trzymające pojemnik na próbkę moczu w laboratorium4.7

Creatinine and eGFR (Estimated Glomerular Filtration Rate)

Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.

Badania krwiStrong evidence
Rzędy probówek z próbkami krwi w stojaku laboratoryjnym4.6

Complete Blood Count (CBC)

The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.

Badania krwiStrong evidence

Related articles

Lekarz notujący szczegóły podczas konsultacji pacjenta w gabineciePoradniki

TRT or Lifestyle Change? What Actually Raises Testosterone Before You Consider Therapy

Before considering testosterone replacement therapy, it's worth checking how much sleep, training, and fat loss can realistically achieve — and when these interventions genuinely aren't enough.

PZdr Piotr Zieliński7 min

July 29, 2026

Para trzymająca się za ręce na zewnątrzPoradniki

TRT and Fertility: Can Testosterone Therapy Cause Infertility?

Testosterone replacement therapy can suppress sperm production even in men with a 'perfect' blood testosterone result — we explain the mechanism, the real scale of the problem, and the concrete options for men who want to have children.

PZdr Piotr Zieliński12 min

August 15, 2026

Zamyślony mężczyzna patrzący w dół w zadumiePoradniki

Normal Testosterone, But You Feel Awful — Could You Still Have Hypogonadism?

A testosterone result that comes back "in range" on a lab printout doesn't always mean everything is hormonally fine — but it doesn't automatically mean you have hypogonadism either. We explain four real explanations for this mismatch, ranked by strength of evidence.

PZdr Piotr Zieliński13 min

August 15, 2026

Para w łóżku — jedna osoba śpi, druga nie może zasnąćPoradniki

TRT and Sleep — Can Testosterone Improve Sleep Quality?

Poor sleep lowers testosterone — that's well documented. But does raising testosterone with replacement therapy improve sleep the other way around? The evidence is much weaker than for other TRT effects, and in some men therapy can actually worsen sleep apnea — so before asking "will it help me sleep," it's worth first asking whether untreated apnea might be the actual source of low testosterone.

PZdr Piotr Zieliński11 min

August 15, 2026

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.